Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherSymposium Article

GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE

Peter G. Wells, Peter I. Mackenzie, Jayanta Roy Chowdhury, Chantal Guillemette, Philip A. Gregory, Yuji Ishii, Antony J. Hansen, Fay K. Kessler, Perry M. Kim, Namita Roy Chowdhury and Joseph K. Ritter
Drug Metabolism and Disposition March 2004, 32 (3) 281-290; DOI: https://doi.org/10.1124/dmd.32.3.281
Peter G. Wells
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter I. Mackenzie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jayanta Roy Chowdhury
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chantal Guillemette
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip A. Gregory
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuji Ishii
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antony J. Hansen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fay K. Kessler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Perry M. Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Namita Roy Chowdhury
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph K. Ritter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 32 no. 3 281-290
DOI 
https://doi.org/10.1124/dmd.32.3.281
PubMed 
14977861

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received October 10, 2003
  • Accepted December 11, 2003
  • Published online February 20, 2004.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Peter G. Wells1,
  2. Peter I. Mackenzie1,
  3. Jayanta Roy Chowdhury1,
  4. Chantal Guillemette1,
  5. Philip A. Gregory,
  6. Yuji Ishii,
  7. Antony J. Hansen,
  8. Fay K. Kessler,
  9. Perry M. Kim,
  10. Namita Roy Chowdhury and
  11. Joseph K. Ritter1
  1. Faculty of Pharmacy and Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada (P.G.W., P.M.K.); Department of Clinical Pharmacology, Flinders Medical Centre, Adelaide, South Australia, Australia (P.I.M., P.A.G., A.J.H.); Graduate School of Pharmaceutical Sciences, Kyushu University (Y.I.), Fukuoka-shi, Kyushu, Japan; Albert Einstein College of Medicine, Yeshiva University, Bronx, New York (J.R.C., N.R.C.); Faculty of Pharmacy, Laval University, Quebec City, Quebec, Canada (C.G.); and Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.K.R., F.K.K.)
  1. Address correspondence to:
    Dr. Joseph K. Ritter, Dept. of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, 410 N. 12th St., P.O. Box 980613, Richmond, VA 23298-0613. E-mail: jritter{at}mail2.vcu.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: February 2004 to January 2021

AbstractFullPdf
Feb 200417490274
Mar 2004127276360
Apr 200449100150
May 200452103101
Jun 2004649170
Jul 2004489547
Aug 20043615138
Sep 20044210533
Oct 20045314473
Nov 2004389634
Dec 20042610063
Jan 20053210458
Feb 20054213289
Mar 200530150157
Apr 200515129104
May 2005269586
Jun 2005209970
Jul 2005189482
Aug 200577969
Sep 2005910979
Oct 2005108389
Nov 2005137962
Dec 200566343
Jan 200698156
Feb 2006107453
Mar 2006147155
Apr 200687558
May 2006166852
Jun 200685345
Jul 2006144945
Aug 200683527
Sep 2006115552
Oct 2006185746
Nov 20062411646
Dec 2006175428
Jan 2007126029
Feb 2007185150
Mar 2007135451
Apr 2007185143
May 200775348
Jun 2007102826
Jul 2007114232
Aug 2007104441
Sep 2007133937
Oct 2007145352
Nov 2007134532
Dec 200764728
Jan 200844036
Feb 2008245941
Mar 2008154452
Apr 2008134645
May 2008193635
Jun 2008204537
Jul 2008154744
Aug 2008147524
Sep 2008485444
Oct 2008173621
Nov 2008262628
Dec 200882421
Jan 2009103735
Feb 2009132831
Mar 2009253318
Apr 200994532
May 2009112630
Jun 2009154127
Jul 200982327
Aug 200972424
Sep 2009121931
Oct 2009302032
Nov 2009253226
Dec 2009141012
Jan 2010192518
Feb 2010341724
Mar 2010282330
Apr 2010352435
May 2010292222
Jun 2010452837
Jul 2010172532
Aug 2010373224
Sep 2010234633
Oct 2010273924
Nov 2010275132
Dec 2010192518
Jan 2011143430
Feb 2011164027
Mar 2011233530
Apr 2011235030
May 2011194922
Jun 2011232224
Jul 2011253024
Aug 2011263734
Sep 2011524545
Oct 2011734331
Nov 2011215325
Dec 2011113726
Jan 2012162221
Feb 2012103424
Mar 2012203038
Apr 2012174326
May 2012226643
Jun 2012196834
Jul 2012114124
Aug 2012192648
Sep 2012152036
Oct 2012161030
Nov 2012191929
Dec 2012163620
Jan 2013254535
Feb 2013213148
Mar 2013183937
Apr 2013324326
May 2013223948
Jun 2013114746
Jul 201342533
Aug 201364127
Sep 2013344518
Oct 2013209527
Nov 2013134123
Dec 2013103927
Jan 201495625
Feb 2014194918
Mar 2014155041
Apr 2014174928
May 2014272958
Jun 2014164717
Jul 2014223326
Aug 2014133746
Sep 2014122470
Oct 2014133415
Nov 2014101718
Dec 2014133135
Jan 2015133613
Feb 20153688
Mar 2015264216
Apr 2015293215
May 2015173317
Jun 2015214619
Jul 201582115
Aug 201593327
Sep 2015182317
Oct 201583610
Nov 2015132417
Dec 2015111712
Jan 2016221217
Feb 2016212312
Mar 2016101917
Apr 2016193711
May 201681618
Jun 201681515
Jul 2016123720
Aug 201613188
Sep 2016102220
Oct 201684226
Nov 201683317
Dec 201632714
Jan 201723523
Feb 201713921
Mar 201774727
Apr 201722426
May 201743122
Jun 201733416
Jul 201745019
Aug 201724215
Sep 201794214
Oct 2017105119
Nov 201788421
Dec 2017114822
Jan 2018106010
Feb 201872912
Mar 201865210
Apr 201847825
May 2018105319
Jun 201846311
Jul 201854912
Aug 201893916
Sep 201883711
Oct 2018117518
Nov 20187809
Dec 20181175913
Jan 201967911
Feb 201951179
Mar 201954117
Apr 20194575
May 20193314
Jun 20194964
Jul 20195111
Aug 20193621
Sep 20192833
Oct 20193232
Nov 20194143
Dec 201946102
Jan 20204584
Feb 20206133
Mar 20202160
Apr 20203322
May 20203373
Jun 20203941
Jul 20201822
Aug 20201933
Sep 202036100
Oct 20202820
Nov 20201554
Dec 202060142
Jan 202139195

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 32 (3)
Drug Metabolism and Disposition
Vol. 32, Issue 3
1 Mar 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherSymposium Article

GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE

Peter G. Wells, Peter I. Mackenzie, Jayanta Roy Chowdhury, Chantal Guillemette, Philip A. Gregory, Yuji Ishii, Antony J. Hansen, Fay K. Kessler, Perry M. Kim, Namita Roy Chowdhury and Joseph K. Ritter
Drug Metabolism and Disposition March 1, 2004, 32 (3) 281-290; DOI: https://doi.org/10.1124/dmd.32.3.281

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
OtherSymposium Article

GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE

Peter G. Wells, Peter I. Mackenzie, Jayanta Roy Chowdhury, Chantal Guillemette, Philip A. Gregory, Yuji Ishii, Antony J. Hansen, Fay K. Kessler, Perry M. Kim, Namita Roy Chowdhury and Joseph K. Ritter
Drug Metabolism and Disposition March 1, 2004, 32 (3) 281-290; DOI: https://doi.org/10.1124/dmd.32.3.281
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Structure and Tissue-Specific Regulation of UGT Genes (P.I.M., P.A.G., Y.I., A.J.H.)
    • Glucuronidation of Xenobiotics and Endobiotics (J.K.R., F.K.K.)
    • Toxicological Relevance of UGTs (P.G.W., P.M.K.)
    • Pharmacogenetics of UGT Enzymes: Implications for Cancer Susceptibility (C.G.)
    • Gene Therapy for UGT Deficiencies (J.R.C., N.R.C.)
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Targeting Drug-Metabolizing Enzymes for Effective Chemoprevention and Chemotherapy
  • TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
Show more SYMPOSIUM ARTICLES

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics